The Department of Defense awarded Johnson & Johnson a contract worth up to $260.5 million to supply it with orthopedic products.

Glooko and Fit4D are combining their offerings to provide patients with an “end-to-end” solution for diabetes management.

MAP Health Management and Lief Therapeutics are tying up to monitor patients with substance use disorder.

Private equity giant KKR is reportedly in “advanced” discussions to acquire a stake in New Delhi-based SRL Diagnostics, a deal potentially worth $775 million.

HTG Molecular Diagnostics is teaming up with Spain’s Instituto Valenciano de Oncología to develop a score to predict breast cancer recurrence.

BD has struck a $24 billion deal to buy C.R. Bard to strengthen its position in the markets for catheters, pumps and other items.

Johnson & Johnson has acquired 3D-printing technology from Tissue Regeneration Systems.

Verily launched Project Baseline, which aims to better understand what it means to be healthy and how health transitions to disease.

Theranos promised CMS it will not run a lab for two years and settled to pay up $4.65 million to Arizona residents who had taken Theranos blood tests.

Boston Scientific has led a $23.1 million Series B investment in in heart failure firm NeuroTronik.